CCS
FMI

Crosspoint Capital Strategies’s Foundation Medicine, Inc. FMI Stock Holding History

Crosspoint Capital Strategies’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-150
Closed -$3K – 944
2015
Q4 		$3K Buy
+150
New +$2.89K ﹤0.01% 895

Other funds holding FMI

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Crosspoint Capital Strategies's FMI Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Foundation Medicine, Inc. (FMI) in Q1 2016, closing a stake of 150 shares — an estimated $3K sold.

Crosspoint Capital Strategies first reported a position in FMI in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 96 funds tracked by Wall St. Rank hold FMI as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Foundation Medicine, Inc. position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 150 Foundation Medicine, Inc. shares in Q1 2016, an estimated $3K.
  • Crosspoint Capital Strategies first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Foundation Medicine, Inc. position peaked at $3K in Q4 2015.
  • 96 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.